Published in Vaccine Weekly, May 3rd, 2006
PATH, an international nonprofit organization with over 27 years of global health experience, will work with public and private-sector partners to identify and test promising pneumococcal vaccines. The 5-year effort is supported by a US$75 million grant from the Bill & Melinda Gates Foundation.
PATH's pneumococcal vaccine effort builds on work begun in 2005 to produce protein-derived vaccines to prevent strains of pneumococcus not...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-05-03)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.